search
ESKD
Trends
- 1Medicare Advantage Transplant Gap Clouds ESKD Trial Enrollment●When Payer Status Becomes a Protocol Variable: What the Medicare Advantage Transplant Gap Means for ESKD Trial Enrollment
A new commentary examines how Medicare Advantage patients with end-stage kidney disease face lower access to kidney transplants, and argues that this payer-driven gap can distort clinical trial enrollment when payer status effectively becomes a hidden protocol variable. If trial populations skew toward traditional Medicare or commercial insurance, results may not generalize to Advantage beneficiaries. The piece is prompting discussion among nephrology researchers about equitable trial design.